Citation Impact
Citing Papers
Extreme genetic risk for type 1A diabetes
2006
Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice
2007 StandoutNobel
Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity
2013 StandoutScience
Predominant Autoantibody Production by Early Human B Cell Precursors
2003 StandoutScience
Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8 + T cells in NOD mice
2008 StandoutNobel
Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
2005 StandoutNobel
Genetic coregulation of age of female sexual maturation and lifespan through circulating IGF1 among inbred mouse strains
2012
Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein
2002 StandoutScience
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
2011
Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes
2005
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Progression to Diabetes in Relatives of Type 1 Diabetic Patients: Mechanisms and Mode of Onset
2009
Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes
2010
Early Autoantibody Responses in Prediabetes Are IgG1 Dominated and Suggest Antigen-Specific Regulation
1999
Collaborative Care for Patients with Depression and Chronic Illnesses
2010
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
2014
Electroencephalography.
1994
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes
2009
Type 1 Diabetes-Associated Autoimmunity: Natural History, Genetic Associations, and Screening
2006
Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease
1994
Thiazolidinediones
2004 Standout
The global burden of diabetic foot disease
2005 Standout
Pathogenesis of Type 1 Diabetes: Implications for Incidence Trends
2011
Role of Autoantibodies in Type 1 Diabetes
2006
A novel monoclonal antibody specific for the N-terminal end of GAD65
2001
Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies
2011
Severe Hypoglycemia and Risks of Vascular Events and Death
2010 Standout
Efforts to Prevent and Halt Autoimmune Beta Cell Destruction
2010
Epidemiology of Type 1 Diabetes
2010
Individualizing treatment targets in diabetes care
2011
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Diabetes-related antibodies in euglycemic subjects
2005
Prediction of Autoantibody Positivity and Progression to Type 1 Diabetes: Diabetes Autoimmunity Study in the Young (DAISY)
2004
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
2011 Standout
Autoimmune Polyendocrine Syndromes
2004
The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence
2010
The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?
2013
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Epidemiology of childhood IDDM in Northern Ireland 1989?1994: Low incidence in areas with highest population density and most household crowding
1996
Serum Insulin and Other Cardiovascular Risk Indicators in Children, Adolescents and Young Adults
1991
Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
2008
Current Antihyperglycemic Treatment Guidelines and Algorithms for Patients with Type 2 Diabetes Mellitus
2010
Record-high incidence of Type I (insulin-dependent) diabetes mellitus in Finnish children
1999
Guidelines for the Primary Prevention of Stroke
2010
Sural nerve myelinated fiber density differences associated with meaningful changes in clinical and electrophysiologic measurements
1996
The Pathogenesis and Natural History of Type 1 Diabetes
2012
Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease
2001 StandoutNobel
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Early social mixing and childhood Type 1 diabetes mellitus: a case–control study in Yorkshire, UK
2000
Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study
2012 Standout
Incorporating Incretin-Based Therapies Into Clinical Practice: Differences Between Glucagon-Like Peptide 1 Receptor Agonists and Dipeptidyl Peptidase 4 Inhibitors
2010
Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates
2013
Diabetes epidemiology as a tool to trigger diabetes research and care
1999
Metazoan MicroRNAs
2018 Standout
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Prediabetes: prediction and prevention trials
2004
Polycystic Ovary Syndrome
1995 Standout
The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus–Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 Study
2011
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
Coincidence of immune‐mediated diseases driven by Th1 and Th 2 subsets suggests a common aetiology. A population‐based study using computerized General Practice data
2002
β-Cell Autoantibodies, Human Leukocyte Antigen II Alleles, and Type 1 Diabetes in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy*
2000
Type 2 diabetes
2017 Standout
Clinical applications of quantitative sensory testing (QST)
1998
Type 2 Diabetes: Assessing the Relative Risks and Benefits of Glucose-lowering Medications
2010
Stepwise or Linear Decrease in Penetrance of Type 1 Diabetes With Lower-Risk HLA Genotypes Over the Past 40 Years
2011
Update on Worldwide Efforts to Prevent Type 1 Diabetes
2008
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015 Standout
Prediction and Pathogenesis in Type 1 Diabetes
2010
The stages of type 1A diabetes: 2005
2005
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
2012 Standout
Gut metagenome in European women with normal, impaired and diabetic glucose control
2013 StandoutNature
Meta-analyses involving cross-over trials: methodological issues
2002 Standout
Type 1 diabetes
2013 Standout
An Updated Review on Cancer Risk Associated with Incretin Mimetics and Enhancers
2015
Prevention of type 1 diabetes: the time has come
2008
Sex-specific genetic architecture of human disease
2008
Isolation of enterovirus strains from children with preclinical Type 1 diabetes
2004
Evidence for enhanced rates of complement activation in serum from patients with newly diagnosed insulin-dependent diabetes mellitus exposed to rat islet cells and complement-dependent induction of islet cell apoptosis
1999
Autoantibodies as predictors of disease
2001
Predicting Obesity in Young Adulthood from Childhood and Parental Obesity
1997 Standout
EFFECTS OF LUTEINIZING HORMONE, INSULIN, INSULIN‐LIKE GROWTH FACTOR‐I AND INSULINLIKE GROWTH FACTOR SMALL BINDING PROTEIN 1 IN THE POLYCYSTIC OVARY SYNDROME
1990
Subjective wellbeing, health, and ageing
2014 StandoutNobel
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY)
2006
Effect of heat shock protein peptide DiaPep277 on ß‐cell function in paediatric and adult patients with recent‐onset diabetes mellitus type 1: two prospective, randomized, double‐blind phase II trials
2006
Insulitis in human type 1 diabetes
2011
HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk
2008
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Clinical Applications of Diabetes Antibody Testing
2009
Expression of beta-cell autoimmunity does not differ between potential dizygotic twins and siblings of patients with type 1 diabetes
2004
Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?
2012
Increase in Fasting Insulin and Glucose over Seven Years with Increasing Weight and Inactivity of Young Adults: The CARDIA Study
1996
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study
2010
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
2016 StandoutNature
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
2009
Trends in the incidence of childhood-onset diabetes in Europe 1989–1998
2001
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Evolution, consequences and future of plant and animal domestication
2002 StandoutNature
Advances in the Prediction and Natural History of Type 1 Diabetes
2010
Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk
2012
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Insulin-dependent diabetes mellitus and its animal models
1999
Clinical trials for drugs against diabetic neuropathy: Can we combine scientific needs with clinical practicalities?
2002
Variation and trends in incidence of childhood diabetes in Europe
2000
Early expression of antiinsulin autoantibodies of humans and the NOD mouse: Evidence for early determination of subsequent diabetes
2000
The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010
1997
Rosiglitazone in the Treatment of Haart-Associated Lipodystrophy – a Randomized Double-Blind Placebo-Controlled Study
2003
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
Is There a Link Between Liraglutide and Pancreatitis? A Post Hoc Review of Pooled and Patient-Level Data From Completed Liraglutide Type 2 Diabetes Clinical Trials
2014
Dynamics of Diabetes-Associated Autoantibodies in Young Children with Human Leukocyte Antigen-Conferred Risk of Type 1 Diabetes Recruited from the General Population
2005
Inherited Variation in Vitamin D Genes Is Associated With Predisposition to Autoimmune Disease Type 1 Diabetes
2011
Primary and secondary prevention of Type 1 diabetes
2012
Type 1 diabetes in the young: the harvest of sorrow goes on
2005
How Does Type 1 Diabetes Develop?
2011
Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis
2001
PPARγAND GLUCOSE HOMEOSTASIS
2002
Guidelines for the Primary Prevention of Stroke
2014 Standout
IDDM1 and Multiple Family History of Type 1 Diabetes Combine to Identify Neonates at High Risk for Type 1 Diabetes
2004
Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population.
1992
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
Pleiotropic Actions of Peroxisome Proliferator–Activated Receptors in Lipid Metabolism and Atherosclerosis
2002
Latent autoimmune diabetes in adults: a guide for the perplexed
2005
Comorbidity Affects the Relationship Between Glycemic Control and Cardiovascular Outcomes in Diabetes
2009
Diabetes Antibody Standardization Program: First Assay Proficiency Evaluation
2003
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
2015
International Diabetes Center Treatment of Type 2 Diabetes Glucose Algorithm
2011
The Idd4 Locus Displays Sex-Specific Epistatic Effects on Type 1 Diabetes Susceptibility in Nonobese Diabetic Mice
2006
Global Prevalence of Diabetes
2004 Standout
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence
2015
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2band dose-dependent requirement of H-2g7for diabetes in NOD mice
2008 StandoutNobel
Effects of Insulin in Relatives of Patients with Type 1 Diabetes Mellitus
2002
THE NOD MOUSE: A Model of Immune Dysregulation
2004
Functional connectivity in the resting brain: A network analysis of the default mode hypothesis
2002 Standout
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
2011
CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune Diabetes
2004 StandoutNobel
Diabetic Somatic Neuropathies
2004 Standout
Diabetic Autonomic Neuropathy
2003 Standout
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
2011
The Environmental Determinants of Diabetes in the Young (TEDDY) Study
2008
Latent Autoimmune Diabetes in Adults
2009
The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)
1998
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
2002
A1C Variability Predicts Incident Cardiovascular Events, Microalbuminuria, and Overt Diabetic Nephropathy in Patients With Type 1 Diabetes
2009
Glucose Excursions Between States of Glycemia With Progression to Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1)
2010
miR-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function
2017
C-Peptide Response and HLA Genotypes in Subjects With Recent-Onset Type 1 Diabetes After Immunotherapy With DiaPep277
2011
Works of Edwin Gale being referenced
Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet β cell microchimerism
2007
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
2008
Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis
1997
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes
2004
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
2009
Relationship between Insulin, Insulin-Like Growth Factor I, and Dehydroepiandrosterone Sulfate Concentrations During Childhood, Puberty, and Adult Life*
1989
Theory and Practice of Nicotinamide Trials in Pre-Type 1 Diabetes
1996
Treatment of Diabetic Neuropathy With γ-Linolenic Acid
1993
Dying of diabetes
2006
Absolute Risk of Childhood-Onset Type 1 Diabetes Defined by Human Leukocyte Antigen Class II Genotype: A Population-Based Study in the United Kingdom
2004
Intensified glucose control in type 2 diabetes—whose agenda?
2010
A Novel Micro-assay for Insulin Autoantibodies
1997
Gridlocked guidelines for diabetes
2010
Lessons from the glitazones: a story of drug development
2001
The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes
2004
The High Prevalence of Autoantibodies to Tissue Transglutaminase in First-Degree Relatives of Patients With Type 1 Diabetes Is Not Associated With Islet Autoimmunity
2001
Is Puberty an Accelerator of Type 1 Diabetes in IL6-174CC Females?
2005
Hypoglycemia in IDDM
1989
Meta-Analysis of the Effect of Insulin Lispro on Severe Hypoglycemia in Patients With Type 1 Diabetes
1998
Standardization of IVGTT to Predict IDDM
1992
The Discovery of Type 1 Diabetes
2001
Prediction of IDDM in the General Population: Strategies Based on Combinations of Autoantibody Markers
1997
Why Can’t We Prevent Type 1 Diabetes?
2003
Rising Incidence of IDDM in Europe
1989
Can We Really Predict IDDM?
1993
High Familial Risk and Genetic Susceptibility in Early Onset Childhood Diabetes
2002
A Critical Analysis of the Clinical Use of Incretin-Based Therapies
2013
Combined Analysis of Autoantibodies Improves Prediction of IDDM in Islet Cell Antibody-Positive Relatives
1994
Can Islet Cell Antibodies Predict IDDM in the General Population?
1993
The Rise of Childhood Type 1 Diabetes in the 20th Century
2002
Effect of Antecedent Glucose Control on Cerebral Function During Hypoglycemia
1991
Insulin Resistance and Progression to Type 1 Diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT)
2007
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
2008